“Taking it to a whole other level.” How Azurion is changing the world of surgery
How Azurion is changing the world of surgery. “Taking it to a whole other level.”
How Azurion is changing the world of surgery. “Taking it to a whole other level.”
The Crick Institute plans to leverage Broken String’s DNA break-mapping platform to develop novel applications for ALS treatments.
The ability to develop crisp mental models around the problems you want to solve and understanding the why before you start working on the how…
Prologue Medicines’ platform combines computation and high-throughput biology to decode millennia of viral evolution.
In one of the opening workshops at ASGCT 2024, topics around delivery methods for gene therapies and approaches to expand the gene editing toolbox dominated…
Casey Ross and Bob Herman report on how UnitedHealth Group used an unregulated algorithm to deny care to seriously ill older and disabled patients.
An optogenetic tool to enable the study of rapid inflammasome responses is described.
Pfizer has paused enrollment in a Phase III trial assessing its Duchenne muscular dystrophy (DMD) gene therapy candidate fordadistrogene movaparvovec after acknowledging the sudden death…
The group practice’s SVP of digital health reveals how she and her team have created new care models, integrated artificial intelligence-enabled clinical decision support and…
The quarter marks the first time the company reported profitability on an adjusted EBITDA basis.
Money for new repatriation program would be better spent supporting researchers who stayed in Brazil, critics say